about
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsLow influenza vaccination rates among child care workers in the United States: assessing knowledge, attitudes, and behaviorsInfluenza vaccination coverage among school employees: assessing knowledge, attitudes, and behaviorsUsing the Ferret as an Animal Model for Investigating Influenza Antiviral EffectivenessA novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activityA contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virusInfluenza and Memory T Cells: How to Awake the ForceThiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational levelPerceptions of pandemic influenza vaccinesHost, weather and virological factors drive norovirus epidemiology: time-series analysis of laboratory surveillance data in England and WalesLearning to Trust Flu Shots: Quasi-Experimental Evidence from the 2009 Swine Flu Pandemic.Adolescent Vaccination Strategies: Interventions to Increase Coverage.Pandemic influenza and the global vaccine supply.Oseltamivir in the management of influenza.Predictive factors associated with the acceptance of pandemic and seasonal influenza vaccination in health care workers and students in Tuscany, Central Italy.Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay.Influenza vaccines: an Asia-Pacific perspective.MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 virusesThe role of oseltamivir in the treatment and prevention of influenza in children.2010 A(H1N1) vaccination in pregnant women in Brazil: identifying coverage and associated factors.Optimal control and sensitivity analysis of an influenza model with treatment and vaccination.Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses.Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1).Recommendations for the prevention and treatment of influenza using antiviral drugs based on cost-effectiveness.Influenza A (H1N1) in Victoria, Australia: a community case series and analysis of household transmission.Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital.Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection.Sickness absenteeism rate in Iranian schools during the 2009 epidemic of type a influenza.Assessing vaccine safety communication with healthcare providers in a large urban county.Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010.Pandemic influenza A (H1N1) 2009: risk factors for hospitalization.Renal complications of seasonal and pandemic influenza A virus infections.Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in miceFactors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data.Personality, psychological stress, and self-reported influenza symptomatology.Critical care aspects of lung transplantation.A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.Health-related behaviors and effectiveness of trivalent inactivated versus live attenuated influenza vaccine in preventing influenza-like illness among young adultsVisualizing clinical evidence: citation networks for the incubation periods of respiratory viral infections.
P2860
Q22305941-BC545E67-87BD-44BB-9299-1DC41853A7ABQ23917648-AA1B9497-495A-4A66-AEB5-705C46ED83ADQ23917653-8497F69E-468D-4DD2-B216-D1B4E0900B65Q27000668-A3356138-056C-4A9A-BF75-01E993DB32A9Q27312788-77867798-C285-40A6-9093-26F9B863A89AQ27316330-2E085AD3-79C6-4CF6-A1D2-8EFCB7529E27Q28070255-306CCBB0-2518-464A-94B2-5D3ED3DF24E9Q28253220-3E9524D3-1195-46C9-BDA2-2136B1633885Q28385275-709D0A1D-13CB-4BE8-9E58-C4C05CDD727CQ28751937-7668481E-D7FA-406D-9BEB-F1A8319ED73DQ30151940-CB40D7AC-16B9-497B-B4B0-38B345A799B6Q30251432-892691AD-8026-4FC6-A9E0-22BBBE924289Q30332964-018EE57D-6DE8-4499-A847-C67E5E89EF7CQ30351736-B9E3BBF5-5008-4399-98FD-40D5BFE6E184Q30352924-C19917E3-4FAC-4B75-95DC-202D4253486FQ30353207-346FDA7E-9EEF-4A07-95E4-7DB6298B0A71Q30355443-5D50CFD7-5A53-442E-8FFC-3F6100F55941Q30358935-F3F9AF08-2ADB-4CFE-947B-C3367722A7F9Q30364977-839A5ED1-AFDF-4DFA-9C1A-4155FC633994Q30377031-7C78A7A7-5101-4107-860A-5C1334F5A4DEQ30385458-8052382C-1A84-499D-B784-0CF098F94173Q30386911-A8695F8C-666A-489D-8F61-7632A162834BQ30389984-75F0C107-E31C-4A5A-B6AA-D8D5F013F334Q30390080-29BBA61D-6C32-464A-84A9-A7B0FC2EB05EQ30396017-AEB944ED-2AE1-415C-9DE0-633D25EF25F3Q30399036-DA230285-38EA-4A23-A0BA-2B67DE23B215Q30406849-84E50305-56DD-4526-BF94-0DAE41EED4F3Q30407084-3EE35005-0A53-49F5-96D6-8BD0AF3402F2Q30407586-E0A8DAC9-7CE2-4ED2-A46F-569F2C0DFF92Q30414118-E0DE71E6-63E2-46D0-8622-65C7416B7824Q30414140-466B1AA4-7B46-4997-86B0-B8D090DB5B62Q30422342-65AB4CCD-F50F-4484-AC20-C103BA252A8EQ30425194-01B638F6-6577-423F-890B-491D25530835Q30425370-F4362B5A-1A48-44D2-A716-FD7F2DB0C413Q31022097-E6BA8576-BB71-40E1-8B16-C427258F0E15Q33307048-CD0667E7-E599-4CB6-A401-F4803B762776Q33360317-2B0265E5-A495-43FC-B720-80300B11DCD9Q33683108-713BAD22-3785-41AF-81D3-94AB83F14AF4Q33889950-4CC14CF1-FEE1-4A5E-87AD-43BF51726E66Q33894836-29FBAA71-0397-4EB7-92E8-53E9DE7A6633
P2860
description
article publié dans la revue scientifique The Lancet
@fr
im Oktober 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 1999
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Influenza
@en
Influenza
@nl
type
label
Influenza
@en
Influenza
@nl
prefLabel
Influenza
@en
Influenza
@nl
P1433
P1476
Influenza
@en
P2093
Nancy J Cox
P304
P356
10.1016/S0140-6736(99)01241-6
P407
P577
1999-10-01T00:00:00Z